Adare Pharmaceuticals Sold to Two Private Equity Firms
Two private equity firms, Thomas H. Lee Partners and Frazier Healthcare Partners, are teaming up to acquire a leading specialty contract development and manufacturing organization (CDMO). The firms are buying Adare Pharmaceuticals. a global provider of advanced pharmaceutical technologies, development and manufacturing. The company utilizes its differentiated pharmaceutical technology and microbiome scientific platforms to develop novel, improved medicines and therapies for the global market. Adare has developed and manufactured more than 40 products sold by partners in more than 100 countries globally including Lacteol, Zoolac, Viactiv, and a number of branded and complex generic... Read More »
Private Equity Still Driving Behavioral Health Deals
As healthcare M&A deal volume drops, particularly in the services sectors, behavioral health targets are still in hot demand, especially for private equity firms. Roughly 18% of deals announced by a PE buyer in the second quarter have targeted companies in the Behavioral Health Care sector, the highest concentration for any of the healthcare sectors. That statistic certainly correlates with the spike in demand for mental health services triggered by the anxiety surrounding COVID-19, as outlined in this article from The Chartis Group, an advisory and analytics services firm focused on the healthcare industry. Additionally, in early March, the U.S Centers for Medicare & Medicaid... Read More »
TPG Invests in LifeStance Health
The need for behavioral health care has only been heightened by the COVID-19 pandemic we are now experiencing. And TPG Capital is moving deeper into the space with its majority investment in LifeStance Health, a leading provider of outpatient behavioral health services. Existing investors Summit Partners and Silversmith Capital Partners remain as minority investors. TPG’s investment is reported to be $1.2 billion, according to PE Hub. Founded in 2017, LifeStance offers a range of outpatient behavioral health services, delivered in-person and through telemedicine. The company focuses on creating and expanding low-cost outpatient access for patients seeking care for behavioral health... Read More »
Hospice Deals Heat Up
It’s been a busy year in the Home Health & Hospice sector. Deal volume is poised to surpass the record 85 transactions announced in 2018. Through late November, 79 deals are in our DealSearchOnline database and more are expected before year-end. Home health agencies account for the bulk of the transactions every year, making up 72% in both 2015 and 2016, for example. In the past two years, however, hospice companies have seen a surge in investor interest. In 2018, hospice companies accounted for 33% of the 85 deals in the sector. Through the end of November 2019, they make up 38% of the sector’s deal count. Valuations are often described as “frothy” for home... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
